Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas

Clinical trial NCT01140360 · COMPLETED

Trial details

NCT number: NCT01140360
Sponsor: Kent Robertson
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis Neurofibromas

Start date: 2012-02-01
Primary completion: 2016-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.